Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Searching for New Biomarkers and the Use of Multivariate Analysis in Gastric Cancer Diagnostics

R. Kucera, D. Smid, O. Topolcan, M. Karlikova, O. Fiala, D. Slouka, T. Skalicky, V. Treska, V. Kulda, V. Simanek, M. Safanda, M. Pesta,

. 2016 ; 36 (4) : 1967-71.

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16027551

AIM: The first aim of this study was to search for new biomarkers to be used in gastric cancer diagnostics. The second aim was to verify the findings presented in literature on a sample of the local population and investigate the risk of gastric cancer in that population using a multivariant statistical analysis. PATIENTS AND METHODS: We assessed a group of 36 patients with gastric cancer and 69 healthy individuals. We determined carcinoembryonic antigen, cancer antigen 19-9, cancer antigen 72-4, matrix metalloproteinases (-1, -2, -7, -8 and -9), osteoprotegerin, osteopontin, prothrombin induced by vitamin K absence-II, pepsinogen I, pepsinogen II, gastrin and Helicobacter pylori for each sample. RESULTS: The multivariate stepwise logistic regression identified the following biomarkers as the best gastric cancer predictors: CEA, CA72-4, pepsinogen I, Helicobacter pylori presence and MMP7. CONCLUSION: CEA and CA72-4 remain the best markers for gastric cancer diagnostics. We suggest a mathematical model for the assessment of risk of gastric cancer.

000      
00000naa a2200000 a 4500
001      
bmc16027551
003      
CZ-PrNML
005      
20170118093234.0
007      
ta
008      
161005s2016 gr f 000 0|eng||
009      
AR
035    __
$a (PubMed)27069188
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Kucera, Radek $u Laboratory of Immunoanalysis, Department of Nuclear Medicine, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
245    10
$a Searching for New Biomarkers and the Use of Multivariate Analysis in Gastric Cancer Diagnostics / $c R. Kucera, D. Smid, O. Topolcan, M. Karlikova, O. Fiala, D. Slouka, T. Skalicky, V. Treska, V. Kulda, V. Simanek, M. Safanda, M. Pesta,
520    9_
$a AIM: The first aim of this study was to search for new biomarkers to be used in gastric cancer diagnostics. The second aim was to verify the findings presented in literature on a sample of the local population and investigate the risk of gastric cancer in that population using a multivariant statistical analysis. PATIENTS AND METHODS: We assessed a group of 36 patients with gastric cancer and 69 healthy individuals. We determined carcinoembryonic antigen, cancer antigen 19-9, cancer antigen 72-4, matrix metalloproteinases (-1, -2, -7, -8 and -9), osteoprotegerin, osteopontin, prothrombin induced by vitamin K absence-II, pepsinogen I, pepsinogen II, gastrin and Helicobacter pylori for each sample. RESULTS: The multivariate stepwise logistic regression identified the following biomarkers as the best gastric cancer predictors: CEA, CA72-4, pepsinogen I, Helicobacter pylori presence and MMP7. CONCLUSION: CEA and CA72-4 remain the best markers for gastric cancer diagnostics. We suggest a mathematical model for the assessment of risk of gastric cancer.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a protilátky bakteriální $x krev $7 D000907
650    _2
$a antigeny sacharidové asociované s nádorem $x krev $7 D015295
650    _2
$a nádorové biomarkery $x krev $7 D014408
650    _2
$a karcinoembryonální antigen $x krev $7 D002272
650    _2
$a infekce vyvolané Helicobacter pylori $x imunologie $7 D016481
650    _2
$a Helicobacter pylori $x imunologie $7 D016480
650    _2
$a lidé $7 D006801
650    _2
$a imunoglobulin G $x krev $7 D007074
650    _2
$a matrixová metaloproteinasa 7 $x krev $7 D020783
650    _2
$a lidé středního věku $7 D008875
650    12
$a teoretické modely $7 D008962
650    _2
$a multivariační analýza $7 D015999
650    _2
$a pepsinogen A $x krev $7 D020116
650    _2
$a rizikové faktory $7 D012307
650    _2
$a nádory žaludku $x krev $x diagnóza $7 D013274
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Smid, David $u Surgical Clinic, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
700    1_
$a Topolcan, Ondrej $u Laboratory of Immunoanalysis, Department of Nuclear Medicine, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Pilsen, Czech Republic topolcan@fnplzen.cz.
700    1_
$a Karlíková, Marie $u Laboratory of Immunoanalysis, Department of Nuclear Medicine, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Pilsen, Czech Republic. $7 mzk2014839291
700    1_
$a Fiala, Ondřej $u Department of Oncology and Radiotherapy, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Pilsen, Czech Republic Biomedical Center, Medical School in Pilsen, Charles University in Prague, Pilsen, Czech Republic. $7 xx0209889
700    1_
$a Slouka, David $u Laboratory of Immunoanalysis, Department of Nuclear Medicine, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
700    1_
$a Skalicky, Tomas $u Surgical Clinic, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
700    1_
$a Treska, Vladislav $u Surgical Clinic, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
700    1_
$a Kulda, Vlastimil $u Institute of Chemistry and Biochemistry, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
700    1_
$a Simanek, Vaclav $u Laboratory of Immunoanalysis, Department of Nuclear Medicine, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
700    1_
$a Safanda, Martin $u Laboratory of Immunoanalysis, Department of Nuclear Medicine, Medical School and Teaching Hospital in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
700    1_
$a Pesta, Martin $u Institute of Biology, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
773    0_
$w MED00000478 $t Anticancer research $x 1791-7530 $g Roč. 36, č. 4 (2016), s. 1967-71
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27069188 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20161005 $b ABA008
991    __
$a 20170118093342 $b ABA008
999    __
$a ok $b bmc $g 1165865 $s 952181
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 36 $c 4 $d 1967-71 $i 1791-7530 $m Anticancer research $n Anticancer Res $x MED00000478
LZP    __
$a Pubmed-20161005

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace